The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 09, 2018
Filed:
Feb. 03, 2017
Applicant:
Zenith Epigenetics Ltd., Calgary, CA;
Inventors:
Shuang Liu, Schenectady, NY (US);
Bryan Cordell Duffy, Glenmont, NY (US);
John Frederick Quinn, Albany, NY (US);
May Xiaowu Jiang, Guilderland, NY (US);
Ruifang Wang, Schenectady, NY (US);
Gregory Scott Martin, Colonie, NY (US);
He Zhao, Madison, CT (US);
Bruce Francis Molino, Slingerlands, NY (US);
Peter Ronald Young, San Francisco, CA (US);
Assignee:
Zenith Epigenetics Ltd., Calgary, AB, CA;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/501 (2006.01); A61K 31/506 (2006.01); A61K 31/4439 (2006.01); A61K 31/497 (2006.01); A61K 31/513 (2006.01); A61K 31/4545 (2006.01); A61K 31/50 (2006.01); A61K 31/498 (2006.01); A61K 31/4709 (2006.01); A61K 31/444 (2006.01); A61K 31/4412 (2006.01); A61K 31/496 (2006.01); A61K 31/472 (2006.01); A61K 31/502 (2006.01); A61K 31/4725 (2006.01); A61K 31/4375 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 31/4375 (2013.01); A61K 31/444 (2013.01); A61K 31/4412 (2013.01); A61K 31/4439 (2013.01); A61K 31/4545 (2013.01); A61K 31/472 (2013.01); A61K 31/4709 (2013.01); A61K 31/4725 (2013.01); A61K 31/496 (2013.01); A61K 31/497 (2013.01); A61K 31/498 (2013.01); A61K 31/50 (2013.01); A61K 31/501 (2013.01); A61K 31/502 (2013.01); A61K 31/506 (2013.01); A61K 31/513 (2013.01);
Abstract
The present disclosure relates to compounds, which are useful for inhibition of BET protein function by binding to bromodomains, and their use in therapy.